Single-cell sequencing and spatial transcriptomics reveal upregulated SGLT2 and ENaC expression in proximal tubular epithelial cells and abnormal TRPC5/TRPC6 ratios in podocytes of DKD patients, highlighting the need for subtype/cell-specific inhibitors (140–143). This evidence concerns the gene SLC5A2 and diabetic kidney disease.